REGEN BIOPHARMA, INC. Convertible Notes Payable
REGEN BIOPHARMA, INC. (RGBP) had Convertible Notes Payable of $726.29 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2026-08-17
- 2026-06-30: Convertible Notes Payable $726.29K.
- 2026-03-31: Convertible Notes Payable $817.72K.
- 2025-12-31: Convertible Notes Payable $947.13K.
- 2025-09-30: Convertible Notes Payable $1.01M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2026-06-30 | $726.29K 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $817.72K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $947.13K 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $1.01M 10-Q · filed 2026-08-17 | |
| 2025-06-30 | $769.90K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $757.27K 10-Q · filed 2025-05-28 | |
| 2024-12-31 | $744.63K 10-Q · filed 2025-05-16 | |
| 2024-09-30 | $499.88K 10-K · filed 2025-12-30 | |
| 2024-06-30 | $499.88K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $499.88K 10-Q · filed 2024-04-24 | |
| 2023-12-31 | $499.88K 10-Q · filed 2024-01-19 | |
| 2023-09-30 | $509.88K 10-K · filed 2025-05-13 | $499.88K 10-K · filed 2023-11-20 |
| 2023-06-30 | $499.88K 10-Q · filed 2023-07-25 | |
| 2023-03-31 | $499.88K 10-Q · filed 2023-04-18 | |
| 2022-12-31 | $499.88K 10-Q · filed 2023-01-19 | |
| 2022-09-30 | $1.26M 10-K · filed 2023-11-20 | |
| 2022-06-30 | $1.57M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $2.99M 10-Q · filed 2022-04-21 | |
| 2021-12-31 | $1.26M 10-Q · filed 2022-01-20 | |
| 2021-09-30 | $2.13M 10-K · filed 2022-11-15 | |
| 2021-06-30 | $2.34M 10-Q/A · filed 2021-12-22 | |
| 2021-03-31 | $2.46M 10-Q · filed 2021-08-18 | |
| 2020-12-31 | $2.50M 10-Q · filed 2021-08-13 | |
| 2020-09-30 | $2.52M 10-Q/A · filed 2021-12-22 | |
| 2020-06-30 | $2.45M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $2.45M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $2.15M 10-Q · filed 2021-08-05 | |
| 2019-12-16 | $350.00K 10-Q · filed 2025-05-28 | |
| 2019-09-30 | $2.05M 10-Q · filed 2021-08-05 | |
| 2019-06-30 | $1.33M 10-Q · filed 2019-10-24 | |
| 2019-03-31 | $942.40K 10-Q · filed 2019-08-29 | |
| 2018-12-31 | $792.48K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $774.67K 10-K · filed 2021-06-21 | |
| 2018-06-30 | $712.76K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $646.46K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $354.33K 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $248.89K 10-K · filed 2018-12-27 | |
| 2017-06-30 | $142.59K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $94.69K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $47.42K 10-Q · filed 2017-01-27 | |
| 2016-09-30 | $9.04K 10-Q · filed 2017-01-27 | |
| 2015-06-30 | $90.00K 10-Q/A · filed 2017-04-28 |